Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Grossman

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Neuro-Oncology|August 30, 2008
Phase II preradiation R115777 (tipifarnib) in newly diagnosed GBM with residual enhancing diseaseRobert Lustig, Tom Mikkelsen, Glenn Lesser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Phase I clinical and pharmacokinetic study of irinotecan in adults with recurrent malignant gliomaMark R Gilbert, Jeffrey G Supko, Tracy Batchelor, et al.
Frontiers in Oncology|October 19, 2020
Blood-Brain Barrier Disruption in Neuro-Oncology: Strategies, Failures, and Challenges to OvercomeBrij S Karmur, Justine Philteos, Aram Abbasian, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 24, 2004
Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: quality and analysis results of a phase I trialN Shastry Akella, Donald B Twieg, Tom Mikkelsen, et al.
Research Square|November 14, 2023
A Multi-Site Phase I Trial of Veliparib with Standard Radiation and Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)Lawrence Kleinberg, Xiaobu Ye, Jeff Supko, et al.
Journal of Neuro-Oncology|November 10, 2016
Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant gliomaEdward Pan, Jeffrey G Supko, Thomas J Kaley, et al.
American Journal of Clinical Oncology|September 17, 2016
Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397)Paul L Moots, Anne O'Neill, Harold Londer, et al.
Neuro-Oncology|September 25, 2016
Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastomaTracy T Batchelor, Elizabeth R Gerstner, Xiaobu Ye, et al.
Plos One|January 29, 2024
Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702John B Fiveash, Xiaobu Ye, David M Peerboom, et al.
Gynecologic Oncology|November 17, 2015
Lymphopenia and its association with survival in patients with locally advanced cervical cancerEmily S Wu, Titilope Oduyebo, Lauren P Cobb, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Neuro-Oncology|August 30, 2008
Phase II preradiation R115777 (tipifarnib) in newly diagnosed GBM with residual enhancing diseaseRobert Lustig, Tom Mikkelsen, Glenn Lesser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Phase I clinical and pharmacokinetic study of irinotecan in adults with recurrent malignant gliomaMark R Gilbert, Jeffrey G Supko, Tracy Batchelor, et al.
Frontiers in Oncology|October 19, 2020
Blood-Brain Barrier Disruption in Neuro-Oncology: Strategies, Failures, and Challenges to OvercomeBrij S Karmur, Justine Philteos, Aram Abbasian, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 24, 2004
Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: quality and analysis results of a phase I trialN Shastry Akella, Donald B Twieg, Tom Mikkelsen, et al.
Research Square|November 14, 2023
A Multi-Site Phase I Trial of Veliparib with Standard Radiation and Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)Lawrence Kleinberg, Xiaobu Ye, Jeff Supko, et al.
Journal of Neuro-Oncology|November 10, 2016
Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant gliomaEdward Pan, Jeffrey G Supko, Thomas J Kaley, et al.
American Journal of Clinical Oncology|September 17, 2016
Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397)Paul L Moots, Anne O'Neill, Harold Londer, et al.
Neuro-Oncology|September 25, 2016
Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastomaTracy T Batchelor, Elizabeth R Gerstner, Xiaobu Ye, et al.
Plos One|January 29, 2024
Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702John B Fiveash, Xiaobu Ye, David M Peerboom, et al.
Gynecologic Oncology|November 17, 2015
Lymphopenia and its association with survival in patients with locally advanced cervical cancerEmily S Wu, Titilope Oduyebo, Lauren P Cobb, et al.
Pageof 3